AstraZeneca spokesperson commented "We are committed to pursuing the opportunity at Speke and are in constructive discussions with the UK government." The spokesperson further added, "We have no ...

AstraZeneca is backing up its considerable ... investment in an expansion of its vaccines manufacturing facility in Speke, near Liverpool, and a new facility at its R&D headquarters in Cambridge ...

A £650 million investment package by AstraZeneca in the UK has been held ... to invest £450 million at its manufacturing site in Speke, Liverpool, to boost research, development, and ...

Delays in securing top-level support meant biotech giant AstraZeneca has missed a key internal deadline on investment in its facility in Speke, Liverpool. The row comes after Business Secretary ...

Tech Climbers returns to the Liverpool City Region next month for a fifth year, celebrating half a decade of profiling the ...

AstraZeneca has updated the efficacy result of its coronavirus vaccine trial in the US, after health officials insisted they wanted to include the latest information. The Anglo-Swedish firm has ...

AstraZeneca's bold vision for a cutting-edge vaccine facility in Speke is caught in a web of delays, leaving the biotech ...